Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Patient preferences and urologist recommendations among local-stage prostate cancer patients who present for initial consultation and second opinions.

Ramsey SD, Zeliadt SB, Fedorenko CR, Blough DK, Moinpour CM, Hall IJ, Smith JL, Ekwueme DU, Fairweather ME, Thompson IM, Keane TE, Penson DF.

World J Urol. 2011 Feb;29(1):3-9. doi: 10.1007/s00345-010-0602-y. Epub 2010 Oct 20.

PMID:
20959991
2.
3.

United States radiation oncologists' and urologists' opinions about screening and treatment of prostate cancer vary by region.

McNaughton Collins M, Barry MJ, Zietman A, Albertsen PC, Talcott JA, Walker Corkery E, Elliott DB, Fowler FJ Jr.

Urology. 2002 Oct;60(4):628-33.

PMID:
12385923
4.

Treatment choice for benign prostatic hyperplasia: a matter of urologist preference?

Stoevelaar HJ, Van de Beek C, Casparie AF, McDonnell J, Nijs HG.

J Urol. 1999 Jan;161(1):133-8.

PMID:
10037385
5.

Perceptions of Active Surveillance and Treatment Recommendations for Low-risk Prostate Cancer: Results from a National Survey of Radiation Oncologists and Urologists.

Kim SP, Gross CP, Nguyen PL, Smaldone MC, Shah ND, Karnes RJ, Thompson RH, Han LC, Yu JB, Trinh QD, Ziegenfuss JY, Sun M, Tilburt JC.

Med Care. 2014 Jul;52(7):579-85. doi: 10.1097/MLR.0000000000000155.

PMID:
24926704
6.

Preliminary treatment considerations among men with newly diagnosed prostate cancer.

Zeliadt SB, Moinpour CM, Blough DK, Penson DF, Hall IJ, Smith JL, Ekwueme DU, Thompson IM, Keane TE, Ramsey SD.

Am J Manag Care. 2010 May 1;16(5):e121-30.

7.

Comparison of urologist reimbursement for managing patients with low-risk prostate cancer by active surveillance versus total prostatectomy.

Manoharan M, Eldefrawy A, Katkoori D, Antebi E, Soloway MS.

Prostate Cancer Prostatic Dis. 2010 Dec;13(4):307-10. doi: 10.1038/pcan.2010.34. Epub 2010 Sep 14.

PMID:
20838414
8.

Clarifying uncertainty regarding detection and treatment of early-stage prostate cancer.

Wilt TJ.

Semin Urol Oncol. 2002 Feb;20(1):10-7. Review.

PMID:
11828353
9.

1997 American Urological Association Gallup survey: Changes in diagnosis and management of prostate cancer and benign prostatic hyperplasia, and other practice trends from 1994 to 1997.

Gee WF, Holtgrewe HL, Blute ML, Miles BJ, Naslund MJ, Nellans RE, O'Leary MP, Thomas R, Painter MR, Meyer JJ, Rohner TJ, Cooper TP, Blizzard R, Fenninger RB, Emmons L.

J Urol. 1998 Nov;160(5):1804-7.

PMID:
9783961
10.

Avoiding obsolescence in advanced prostate cancer management: a guide for urologists.

Shore ND, Karsh L, Gomella LG, Keane TE, Concepcion RS, Crawford ED.

BJU Int. 2015 Feb;115(2):188-97. Review.

PMID:
25756134
11.

Practice trends in the diagnosis and management of prostate cancer in the United States.

Gee WF, Holtgrewe HL, Albertsen PC, Litwin MS, Manyak MJ, O'Leary MP, Painter MR.

J Urol. 1995 Jul;154(1):207-8.

PMID:
7539862
12.

Prostate cancer screening and beliefs about treatment efficacy: a national survey of primary care physicians and urologists.

Fowler FJ Jr, Bin L, Collins MM, Roberts RG, Oesterling JE, Wasson JH, Barry MJ.

Am J Med. 1998 Jun;104(6):526-32.

PMID:
9674714
13.

Variation in prostate cancer management.

Burki TK.

Lancet Oncol. 2014 Sep;15(10):e419. No abstract available.

PMID:
25328941
14.

Initiation of salvage therapy for prostate cancer.

Johnstone PA, Booth R, Riffenburgh RH, Amling CL, Kane CJ, Moul JW.

Prostate Cancer Prostatic Dis. 2002;5(2):136-43.

15.

A nationwide survey of practicing urologists: current management of benign prostatic hyperplasia and clinically localized prostate cancer.

Barry MJ, Fowler FJ Jr, Bin L, Oesterling JE.

J Urol. 1997 Aug;158(2):488-91; discussion 492.

PMID:
9224330
16.

The influence of patient race and social vulnerability on urologist treatment recommendations in localized prostate carcinoma.

Denberg TD, Kim FJ, Flanigan RC, Fairclough D, Beaty BL, Steiner JF, Hoffman RM.

Med Care. 2006 Dec;44(12):1137-41.

PMID:
17122719
17.

The age of the urologist affects the postoperative care of prostate carcinoma patients.

Tsai DY, Virgo KS, Colberg JW, Ornstein DK, Johnson ET, Chan D, Johnson FE.

Cancer. 1999 Oct 1;86(7):1314-21.

PMID:
10506719
18.

Patterns of treatment of patients with prostate cancer initially managed with surveillance: results from The CaPSURE database. Cancer of the Prostate Strategic Urological Research Endeavor.

Koppie TM, Grossfeld GD, Miller D, Yu J, Stier D, Broering JM, Lubeck D, Henning JM, Flanders SC, Carroll PR.

J Urol. 2000 Jul;164(1):81-8.

PMID:
10840429
19.

Differences between urologists in the United States and Canada in the approach to prostate cancer.

Fleshner N, Rakovitch E, Klotz L.

J Urol. 2000 May;163(5):1461-6.

PMID:
10751858
20.

What information are urologists extracting from prostate needle biopsy reports and what do they need for clinical management of prostate cancer?

Descazeaud A, Rubin MA, Allory Y, Burchardt M, Salomon L, Chopin D, Abbou C, de la Taille A.

Eur Urol. 2005 Dec;48(6):911-5. Epub 2005 Aug 9.

PMID:
16140457

Supplemental Content

Support Center